Marks; Philip
Patent Applications and Registrations
Patent applications and USPTO patent grants for Marks; Philip.The latest application filed is for "production of activated clostridial neurotoxins".
Company Profile
4.37.33
- Marks; Philip - Abingdon GB
- Marks; Philip - Oxon GB
- Marks; Philip - Wrexham GB
- Marks; Philip - Salisbury N/A GB
- Marks; Philip - Oxfordshire GB
- Marks; Philip - Wiltshire GB
- Marks; Philip - New York NY
Patent Activity
| Patent | Date |
|---|---|
| Production of activated clostridial neurotoxins Grant 11,453,903 - Lovelock , et al. September 27, 2 | 2022-09-27 |
| Suppression of prostate cancer using a targeted clostridial neurotoxin Grant 10,550,377 - Madec , et al. Fe | 2020-02-04 |
| Production Of Activated Clostridial Neurotoxins App 20190161783 - LOVELOCK; Laura ; et al. | 2019-05-30 |
| Suppression Of Cancer App 20190127718 - Madec; Frederic ; et al. | 2019-05-02 |
| Polypeptides that bind to and inhibit secretion from growth hormone secreting cells Grant 10,240,138 - Madec , et al. | 2019-03-26 |
| Suppression of cancer Grant 10,113,159 - Madec , et al. October 30, 2 | 2018-10-30 |
| Recombinant clostridium botulinum neurotoxins Grant 10,030,238 - Cossins , et al. July 24, 2 | 2018-07-24 |
| Fusion proteins Grant 9,243,301 - Foster , et al. January 26, 2 | 2016-01-26 |
| Treatment of pain Grant 9,072,736 - Foster , et al. July 7, 2 | 2015-07-07 |
| Recombinant toxin fragments Grant 9,006,395 - Shone , et al. April 14, 2 | 2015-04-14 |
| Fusion proteins Grant 8,956,847 - Foster , et al. February 17, 2 | 2015-02-17 |
| Fusion proteins Grant 8,940,870 - Foster , et al. January 27, 2 | 2015-01-27 |
| Suppression Of Neuroendocrine Diseases App 20140302006 - JOHNSTONE; Steven ; et al. | 2014-10-09 |
| Suppression Of Cancer App 20140286925 - MADEC; Frederic ; et al. | 2014-09-25 |
| Suppression Of Cancers App 20140219983 - MADEC; Frederic ; et al. | 2014-08-07 |
| Suppression of neuroendocrine diseases Grant 8,796,216 - Johnstone , et al. August 5, 2 | 2014-08-05 |
| Fusion Proteins App 20130189238 - FOSTER; Keith ; et al. | 2013-07-25 |
| Recombinant toxin fragments Grant 8,454,976 - Shone , et al. June 4, 2 | 2013-06-04 |
| Fusion Proteins App 20130115682 - FOSTER; Keith Alan ; et al. | 2013-05-09 |
| Fusion proteins Grant 8,399,400 - Foster , et al. March 19, 2 | 2013-03-19 |
| Fusion proteins Grant 8,399,401 - Foster , et al. March 19, 2 | 2013-03-19 |
| Fusion proteins Grant 8,372,615 - Foster , et al. February 12, 2 | 2013-02-12 |
| Fusion Proteins App 20120230975 - Foster; Keith ; et al. | 2012-09-13 |
| Treatment Of Pain App 20120189610 - Foster; Keith ; et al. | 2012-07-26 |
| Fusion Proteins App 20120149084 - FOSTER; Keith Alan ; et al. | 2012-06-14 |
| Fusion Proteins App 20120064059 - FOSTER; Keith ; et al. | 2012-03-15 |
| Fusion proteins Grant 8,124,074 - Foster , et al. February 28, 2 | 2012-02-28 |
| Fusion proteins Grant 8,124,405 - Foster , et al. February 28, 2 | 2012-02-28 |
| Fusion proteins Grant 8,067,200 - Foster , et al. November 29, 2 | 2011-11-29 |
| Recombinant toxin fragments Grant 8,017,134 - Shone , et al. September 13, 2 | 2011-09-13 |
| Recombinant toxin fragments Grant 8,012,491 - Shone , et al. September 6, 2 | 2011-09-06 |
| Recombinant toxin fragments Grant 8,012,479 - Shone , et al. September 6, 2 | 2011-09-06 |
| Suppression Of Neuroendocrine Diseases App 20110171191 - Johnstone; Stephen ; et al. | 2011-07-14 |
| Suppression Of Cancers App 20110165137 - Madec; Frederic ; et al. | 2011-07-07 |
| Suppression Of Neuroendocrine Diseases App 20110160135 - JOHNSTONE; Stephen ; et al. | 2011-06-30 |
| Suppression Of Cancers App 20110158973 - MADEC; Frederic ; et al. | 2011-06-30 |
| Fusion Proteins App 20110091437 - Foster; Keith ; et al. | 2011-04-21 |
| Recombinant toxin fragments Grant 7,897,158 - Shone , et al. March 1, 2 | 2011-03-01 |
| Fusion Proteins App 20110027256 - FOSTER; Keith ; et al. | 2011-02-03 |
| Recombinant Toxin Fragments App 20110028691 - SHONE; Clifford Charles ; et al. | 2011-02-03 |
| Fusion Proteins App 20100247509 - Foster; Keith ; et al. | 2010-09-30 |
| Recombinant toxin fragments Grant 7,674,470 - Shone , et al. March 9, 2 | 2010-03-09 |
| Treatment Of Pain App 20100034802 - Foster; Keith ; et al. | 2010-02-11 |
| Fusion proteins Grant 7,659,092 - Foster , et al. February 9, 2 | 2010-02-09 |
| Recombinant Toxin Fragments App 20100022751 - Shone; Clifford Charles ; et al. | 2010-01-28 |
| Recombinant Toxin Fragments App 20090274708 - SHONE; Charles Clifford ; et al. | 2009-11-05 |
| Recombinant Toxin Fragments App 20090246827 - Shone; Clifford Charles ; et al. | 2009-10-01 |
| Recombinant Toxin Fragments App 20090148888 - Shone; Clifford Charles ; et al. | 2009-06-11 |
| Fusion Proteins App 20090035822 - Foster; Keith ; et al. | 2009-02-05 |
| Fusion Proteins App 20090004174 - Foster; Keith Alan ; et al. | 2009-01-01 |
| Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics Grant 7,452,543 - Chaddock , et al. November 18, 2 | 2008-11-18 |
| Fusion Proteins App 20080064092 - FOSTER; Keith Alan ; et al. | 2008-03-13 |
| Recombinant toxin fragments App 20070248626 - Shone; Clifford Charles ; et al. | 2007-10-25 |
| Recombinant toxin fragments App 20070184070 - Shone; Clifford Charles ; et al. | 2007-08-09 |
| Recombinant toxin fragments Grant 7,192,596 - Shone , et al. March 20, 2 | 2007-03-20 |
| Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics App 20060121056 - Chaddock; John Andrew ; et al. | 2006-06-08 |
| Recombinant toxin fragments App 20060110410 - Shone; Clifford Charles ; et al. | 2006-05-25 |
| Recombinant toxin fragments App 20050244435 - Shone, Charles Clifford ; et al. | 2005-11-03 |
| Recombinant toxin fragments App 20030166238 - Shone, Clifford Charles ; et al. | 2003-09-04 |
| Combined shipping, storage and serving unit for bottles of wine or the like Grant D261,479 - Marks October 27, 1 | 1981-10-27 |
| Display receptacle Grant D256,644 - Marks September 2, 1 | 1980-09-02 |
Company Registrations
| SEC | 0001249725 | MARKS PHILIP |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 